Literature DB >> 2776860

In vivo effects of immunostimulating lipopeptides on mouse liver microsomal cytochromes P-450 and on paracetamol-induced toxicity.

D Migliore-Samour1, M Delaforge, M Jaouen, D Mansuy, P Jollès.   

Abstract

Immunomodulating lipopeptides lauroyl-L-Ala-gamma-D-Glu-LL-A2pmNH2-Gly (RP 44.102) and lauroyl-L-Ala-gamma-D-Glu-LL-A2pmNH2 (RP 56.142) were found to protect mice against the hepatotoxicity of paracetamol, which is due to cytochrome P-450 dependent formation of toxic metabolites and radicals. In fact they decreased the amount of hepatic microsomal cytochrome P-450, and the level of CCl4-induced lipid peroxidation. In contrast lauroyl-L-Ala-gamma-D-Glu-DD-A2pmNH2 (RP 53.204), which only differs by the configuration of the two chiral carbons of A2pm (diaminopimelic acid) and is not an immunomodulating agent, failed to protect against poisoning by paracetamol and had no effect on the level of hepatic cytochrome P-450 or the microsomal CCl4-induced lipid peroxidation. This provides a clear connection between the immunostimulating properties of a compound and its effects on xenobiotic biotransformations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2776860     DOI: 10.1007/BF01954064

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  20 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  The role of lymphocytes, macrophages and interferon in the depression of drug metabolism by dextran sulfate.

Authors:  T C Peterson; K W Renton
Journal:  Immunopharmacology       Date:  1986-02

3.  Induction of tolerance in mice and rats to the effect of endotoxin to decrease the hepatic microsomal mixed-function oxidase system. Evidence for a possible macrophage-derived factor in the endotoxin effect.

Authors:  J F Williams
Journal:  Int J Immunopharmacol       Date:  1985

4.  Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism.

Authors:  J R Mitchell; D J Jollow; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

5.  Potentiation and suppression of mouse liver cytochrome P-450 isozymes during the acute-phase response induced by bacterial endotoxin.

Authors:  L A Stanley; D J Adams; R Lindsay; R R Meehan; W Liao; C R Wolf
Journal:  Eur J Biochem       Date:  1988-05-16

6.  Relationship between the antiviral effects of interferons and their abilities to depress cytochrome P-450.

Authors:  K W Renton; G Singh; N Stebbing
Journal:  Biochem Pharmacol       Date:  1984-12-01       Impact factor: 5.858

7.  A short lipopeptide, representative of a new family of immunological adjuvants devoid of sugar.

Authors:  D Migliore-Samour; J Bouchaudon; F Floc'h; A Zerial; L Ninet; G H Werner; P Jollès
Journal:  Life Sci       Date:  1980-03-17       Impact factor: 5.037

8.  Immunopotentiating activities of a low molecular weight lipopeptide, RP 56 142--studies in infectious models.

Authors:  F Floc'h; J Poirier
Journal:  Int J Immunopharmacol       Date:  1988

9.  The prevention of acetaminophen-induced hepatotoxicity by the interferon inducer poly(rI . rC).

Authors:  K W Renton; G Dickson
Journal:  Toxicol Appl Pharmacol       Date:  1984-01       Impact factor: 4.219

10.  Effects of interferon-inducing agents on hepatic cytochrome P-450 drug metabolizing systems.

Authors:  G J Mannering; K W Renton; R el Azhary; L B Deloria
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

View more
  2 in total

1.  Immunostimulating lipopeptide, LtriP (RP 56142): comparison of the effect on hepatic cytochrome P 450 modulation and radioprotection in male and female of three mouse strains.

Authors:  M Sedqi; M Delaforge; D Mansuy; B Martin; P Jollès; D Migliore-Samour
Journal:  Experientia       Date:  1995-08-16

2.  Radioprotective effects of the immunostimulating lauroylpeptide LtriP (RP 56142).

Authors:  D Migliore-Samour; A Bousseau; J M Caillaud; A Naussac; M Sedqi; C Ferradini; P Jollès
Journal:  Experientia       Date:  1993-02-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.